About The MTC
Founded by Dr. David J. Sugarbaker, The Mesothelioma Treatment Center (MTC) at Baylor St. Luke's Medical Center is focused on achieving the best possible outcome for patients with malignant pleural mesothelioma. Dr. R. Taylor Ripley was recruited from the National Cancer Institute, NIH, and serves as the Director of the MTC. He has cared for patients with mesothelioma since his training at Memorial Sloan-Kettering Cancer Center and continues Dr. Sugarbaker’s focus on advancing the care of patients with mesothelioma.
High-quality patient care, an outstanding research program, and robust patient and family support efforts are the hallmarks of the center.
The personalized treatment given at the Mesothelioma Treatment Center means that each regimen is tailored to the patient based on his/her unique situation. Often, this treatment involves surgery to remove as much of the tumor as possible, followed by chemotherapy and/or radiation to kill any remaining cancer cells. Additionally, patients are often enrolled in clinical trials Our specialized team has refined the surgical techniques to improve outcomes for mesothelioma patients. Additionally, the clinicians at the MTC are actively engaged in basic and clinical research, which continues to lead to significant improvements in outcomes for patients. Patients are often enrolled in clinical trials that we believe may help battle this disease.
Physicians at the Mesothelioma Treatment Center place patient- and family-centered care first, ensuring that patients are active participants in their own treatment. The MTC support staff understands and respects the importance of caring for the emotional needs of the whole family through support groups and other resources.
"My personal goal, and that of the entire team, is on finding a cure. We will continue our battle with this disease and commit to doing our very best for each patient and family we treat." – Dr. David J. Sugarbaker, Founder